GPT and Hepatic steatosis: Both low AST and ALT without hepatic steatosis were associated with cancer mortality compared with deciles 4–9 (AST without NAFLD: HR = 1.82, 95% CI = 1.40–2.36; ALT without NAFLD: HR = 1.46, 95% CI = 1.17–1.82).